Tag: InsurTech investments
European InsurTech investments plummeted by 64% YoY amid market uncertainties in...
Key European InsurTech investment stats in Q3 2025:
European InsurTech investments plummeted by 64% YoY in Q3
Average deal value halved to $13.9m as...
US companies dominated the global InsurTech deal market with 80% of...
Key global InsurTech investment stats in Q3 2025:
Global InsurTech deal activity grew by 8% YoY
US companies secured 80% of the top 10...
French InsurTech funding surged by 3x in 2024 as investors prioritised...
Key French InsurTech investment stats in 2024:
French InsurTech funding surged by 3x in 2024
Average deal increased to $31m as investors prioritised higher...
India cemented its place as the leading InsurTech hub in Asia...
Key Asian InsurTech investment stats in 2024:
Asian InsurTech deal activity dropped by 64% YoY
India secured over a third of the Asian InsurTech...
US InsurTech funding doubled in Q3 YoY as investors back fewer...
Key United States InsurTech investment stats in Q3 2024:
United States InsurTech funding doubled in Q3 YoY
Deal activity halved in Q3 as investors...
US and French companies occupied the top 10 InsurTech deals spots...
Key Global InsurTech investment stats in Q3 2024:
Global InsurTech deal activity dropped by 49% YoY
US and French companies completed all of the...
US InsurTech funding doubled in Q3 with California-based companies closing quarter...
Key US InsurTech investment stats in Q3 2024:
US InsurTech funding doubled in Q3 YoY
California continues to dominate the US InsurTech space after...
UK InsurTech market recorded zero deals over $100m in the first...
Key UK InsurTech investment stats in H1 2024:
UK InsurTech investments continued to drop in H1 2024, which caused the region to not report...
Funding for InsurTech companies in US dropped by 67% YoY as...
Key US InsurTech investment stats in Q2 2024:
US InsurTech funding dropped by 67% YoY during the second quarter
The average deal size completed...
© InsurTech Analyst © Copyright 2024. All rights reserved.
